To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
NCT00518219
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Membranous Nephropathy
Interventions
DRUG:
TW
Sponsor
Nanjing University School of Medicine